SCHEMBL31196427

SCHEMBL31196427

Cn1ccn(-c2ccc(Cl)c(F)c2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 1/20 0.43
▸ LCK P06239 1/20 0.39
▸ KIT P10721 1/20 0.39
▸ SRC P12931 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ PAK1 Q13153 1/20 0.39
▸ RAD51 Q06609 1/20 0.38
▸ GRM1 Q13255 1/20 0.38
▸ IDO1 P14902 1/20 0.37
▸ TDO2 P48775 1/20 0.37
▸ BRD4 O60885 2/20 0.37
▸ BRD2 P25440 2/20 0.37
▸ BRD3 Q15059 2/20 0.37
▸ CREBBP Q92793 2/20 0.37
▸ BRD9 Q9H8M2 1/20 0.37
▸ EGFR P00533 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12362749 0.81 ALDH1A1 (0.37) MAPTPAK1
SCHEMBL12362761 0.81 ESR1 (0.44) POLBRXFP1
SCHEMBL30930929 0.71 IDO1 (0.35) LMNATP53MAPTPAK1IDO1
SCHEMBL11388929 0.70 PAK1 (0.39) PAK1
SCHEMBL17664675 0.70 RGS4 (0.47) LMNAGRM1
SCHEMBL30931019 0.69 PTGS2 (0.36) LMNAMAPTPAK1RAD51EGFR
SCHEMBL11393218 0.69 NPBWR1 (0.39) LMNAMAPTRAD51EGFRF10
SCHEMBL11402098 0.69 PAK1 (0.36) LCKLMNAMAPTPAK1EGFR
SCHEMBL12362740 0.68 TDP1 (0.41) LMNAMAPTPOLB
SCHEMBL22349820 0.68 GSK3A (0.44) GRM1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709716-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2026-03-18 — — EP disclosed
WO-2024233554-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2024-11-14 — — WO disclosed
Send feedback